Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Gentamicin
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Medical uses== Gentamicin is active against a wide range of bacterial infections, mostly Gram-negative bacteria including ''[[Pseudomonas]]'', ''[[Proteus (bacterium)|Proteus]]'', ''[[Escherichia coli]]'', ''[[Klebsiella pneumoniae]]'', ''Enterobacter aerogenes'', ''[[Serratia]]'', and the Gram-positive ''[[Staphylococcus]]''.<ref name="Baxter Corporation">{{Cite web|url = http://www.baxter.ca/en/downloads/product_information/GENTAMICIN(E)_PM_AUG282012_EN.pdf|title = Gentamicin|access-date = 2 November 2015|publisher = Baxter Corporation|url-status = dead|archive-url = https://web.archive.org/web/20160304124731/http://www.baxter.ca/en/downloads/product_information/GENTAMICIN(E)_PM_AUG282012_EN.pdf|archive-date = 4 March 2016}}</ref> Gentamicin is used in the treatment of respiratory tract infections, urinary tract infections, blood, bone and soft tissue infections of these susceptible bacteria.<ref name="Product Monograph">{{Cite web|url = http://www.sandoz.ca/cs/groups/public/@sge_ca/documents/document/n_prod_1301121.pdf|title = Gentamicin Injection USP | work = Product Monograph|access-date = 2 November 2015|publisher = Sandoz Canada Inc|url-status = dead|archive-url = https://web.archive.org/web/20150412102019/http://www.sandoz.ca/cs/groups/public/%40sge_ca/documents/document/n_prod_1301121.pdf|archive-date = 12 April 2015}}</ref> There is insufficient evidence to support gentamicin as the first line treatment of ''[[Neisseria gonorrhoeae]]'' infection.<ref>{{cite journal | vauthors = Hathorn E, Dhasmana D, Duley L, Ross JD | title = The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review | journal = Systematic Reviews | volume = 3 | pages = 104 | date = September 2014 | pmid = 25239090 | pmc = 4188483 | doi = 10.1186/2046-4053-3-104 | doi-access = free }}</ref> Gentamicin is not used for ''[[Neisseria meningitidis]]'' or ''[[Legionella pneumophila]]'' bacterial infections (because of the risk of the person going into shock from lipid A [[endotoxin]] found in certain Gram-negative organisms). Gentamicin is also useful against ''[[Yersinia pestis]]'' (responsible for [[Plague (disease)|plague]]), its relatives, and ''[[Francisella tularensis]]'' (the organism responsible for [[tularemia]] often seen in hunters and trappers).<ref>{{cite book| vauthors = Goljan EF |title = Rapid Review Pathology|edition = 3rd|year = 2011|publisher = Elsevier|location = Philadelphia, Pennsylvania|isbn = 978-0-323-08438-3|pages = 241}}</ref> Some ''[[Enterobacteriaceae]]'', ''[[Pseudomonas]] spp.'', ''[[Enterococcus]] spp.'', ''[[Staphylococcus aureus]]'' and other ''Staphylococcus spp.'' have varying degrees of [[antimicrobial resistance|resistance]] to gentamicin.<ref>{{cite web|title = Gentamicin spectrum of bacterial susceptibility and Resistance|url = http://www.toku-e.com/Upload/Products/PDS/20120604005203.pdf | publisher = TOKU-E |access-date = 15 May 2012|url-status = dead|archive-url = https://web.archive.org/web/20150220033338/http://www.toku-e.com/Upload/Products/PDS/20120604005203.pdf|archive-date = 20 February 2015}}</ref> ===Special populations=== ====Pregnancy and breastfeeding==== Gentamicin is not recommended in pregnancy unless the benefits outweigh the risks for the mother. Gentamicin can cross the [[placenta]] and several reports of [[congenital hearing loss|irreversible bilateral congenital deafness]] in children have been seen. [[Intramuscular injection|Intramuscular]] injection of gentamicin in mothers can cause [[muscle weakness]] in the [[newborn]].<ref name="Product Monograph" /> The safety and efficacy for gentamicin in nursing mothers has not been established. Detectable gentamicin levels are found in human breast milk and in nursing babies.<ref name="Product Monograph" /> ====Elderly==== In the elderly, [[renal function]] should be assessed before beginning therapy as well as during treatment due to a decline in glomerular filtration rate. Gentamicin levels in the body can remain higher for a longer period of time in this population. Gentamicin should be used cautiously in persons with [[Kidney|renal]], [[Auditory system|auditory]], [[Vestibular system|vestibular]], or [[Neuromuscular junction|neuromuscular]] dysfunction.<ref name="Baxter Corporation" /> ====Children==== Gentamicin may not be appropriate to use in children, including babies. Studies have shown higher [[Serum (blood)|serum]] levels and a longer [[half-life]] in this population.<ref>{{cite journal | vauthors = Sato Y | title = Pharmacokinetics of antibiotics in neonates | journal = Acta Paediatrica Japonica | volume = 39 | issue = 1 | pages = 124β131 | date = February 1997 | pmid = 9124044 | doi = 10.1111/j.1442-200X.1997.tb03569.x | s2cid = 23564581 }}</ref> [[Kidney function]] should be checked periodically during therapy. Long-term effects of treatment can include hearing loss and balance problems. [[Hypocalcemia]], [[hypokalemia]], and [[muscle weakness]] have been reported when used by injection.<ref name="Baxter Corporation" />
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)